The global mRNA vaccine market is expected to grow at a significant CAGR during the forecast period (2021-2027). The mRNA is a single-stranded molecule that carries genetic code from DNA in a cell’s nucleus to ribosome that provides a basis for protein synthesis within the cells. The mRNA vaccines and therapeutics include non-replicating mRNA, in-vivo self-replicating mRNA, and in-vitro dendritic cell non-replicating mRNA vaccine that comprise the desirable immunological properties. Enhanced immunogenicity, rapid development, higher potency, efficacy against pathogens, relatively economical and safer over the conventional vaccines are the key benefits that mRNA vaccines offer. The rising adoption of the mRNA vaccines owing to its offered benefits is a major factor contributing towards the growth of the global mRNA vaccine market.
To Request a Sample of our Report on mRNA Vaccine Market: https://www.omrglobal.com/request-sample/mrna-vaccine-market
The mRNA vaccine finds their use in the treatment of infectious diseases, immuno-oncology, rare diseases, and CVD. The rising prevalence of chronic diseases such as diabetes, tuberculosis, cancer and CVD, among others along with the rising adoption of the mRNA vaccines owing to their high efficacy is promoting the mRNA vaccine manufacturers to enter into agreement with prominent vaccine developers to expedite the manufacturing process. In 2019, among European countries, the prevalence of diabetes was highest in Germany with 15.3% aged populations living with diabetes. Moreover, rising funding in the R&D of mRNA vaccines is further anticipated to boost the market growth. For instance, in March 2020, Janssen Global Services, LLC (Johnson & Johnson) had entered into partnership with the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services to fund over $1 billion in the R&D of COVID-19 vaccine and antiviral treatment. However, strict regulatory criteria, lack of skilled workforce and storage related issues may restrain the growth of the global mRNA vaccine market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: AstraZeneca plc, Pfizer Inc., and Sanofi SA, among others.
(Get 15% Discount on Buying this Report)
A full Report of mRNA Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/mrna-vaccine-market
Global mRNA Vaccine Market Report by Segment
By Type
- Bioengineered Vaccine
- Gene Therapy
- Cell Therapy
- Monoclonal Anti-Body Based Treatment
- Others
By Application
- Infectious Disease Vaccines
- Cancer Vaccines
Global mRNA Vaccine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
